BridgeBio Pharma, Inc.
NASDAQ:BBIO
32.59 (USD) • At close March 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -543.347 | -643.202 | -484.652 | -586.454 | -505.488 | -288.585 | -169.451 | -43.832 |
| Depreciation & Amortization
| 6.075 | 6.494 | 6.771 | 5.843 | 3.088 | 0.859 | 0.245 | 0.26 |
| Deferred Income Tax
| 0 | 0 | 0 | -30.93 | -1.866 | -0.859 | -14.89 | -0.26 |
| Stock Based Compensation
| 95.8 | 0 | 91.559 | 99.505 | 58.459 | 21.374 | 6.067 | 1.841 |
| Change In Working Capital
| 0 | 5.057 | 28.079 | -4.396 | 14.934 | -10.915 | 22.491 | 1.243 |
| Accounts Receivables
| -2.971 | 15.328 | 15.169 | -19.749 | 2.845 | -2.845 | 0 | 0 |
| Inventory
| 0 | 0 | -15.169 | 19.749 | -2.845 | 2.845 | 0 | 0 |
| Accounts Payables
| 1.512 | 2.78 | -0.349 | 2.833 | -0.735 | -4.657 | 16.7 | 1.577 |
| Other Working Capital
| 0 | -13.051 | 28.428 | -7.229 | 15.669 | -6.258 | 5.791 | -0.334 |
| Other Non Cash Items
| -79.254 | 103.931 | -61.251 | 18.498 | 31.159 | 24.539 | 18.895 | 0.26 |
| Operating Cash Flow
| -520.726 | -527.72 | -419.494 | -497.934 | -399.714 | -253.587 | -136.643 | -40.488 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -0.933 | -1.306 | -6.321 | -48.246 | -7.518 | -5.138 | -18.178 | -0.464 |
| Acquisitions Net
| -0.14 | 0 | 120 | -35 | 21.241 | -5.491 | -2.858 | 2.839 |
| Purchases Of Investments
| -88.4 | -137.264 | -193.055 | -643.275 | -287.852 | -212.899 | 0 | 0 |
| Sales Maturities Of Investments
| 158.229 | 193.106 | 532.523 | 477.041 | 242.23 | 5.491 | 0 | 0 |
| Other Investing Activites
| -7.975 | -0.503 | 120 | 48.654 | -21.094 | 0.784 | -2.858 | 0 |
| Investing Cash Flow
| 60.781 | 54.033 | 453.147 | -200.826 | -52.993 | -217.253 | -21.036 | -0.464 |
| Financing Activities: | ||||||||
| Debt Repayment
| 476.583 | 0 | -20.486 | 1,079.677 | 550 | 36.939 | 56.378 | 4.132 |
| Common Stock Issued
| 314.741 | 449.81 | 4.852 | 0 | 0 | 366.237 | 95.536 | 107.163 |
| Common Stock Repurchased
| -7.526 | -6.88 | -1.561 | -204.746 | -75.714 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | -0.997 | 0 | -1.151 |
| Other Financing Activities
| -35.341 | 8.605 | 4.061 | -138.485 | -27.097 | -4.384 | 349.634 | 108.851 |
| Financing Cash Flow
| 748.457 | 451.535 | -13.134 | 736.446 | 447.189 | 398.792 | 501.548 | 112.983 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 288.512 | -22.152 | 20.519 | 37.686 | -5.518 | -72.048 | 343.869 | 72.031 |
| Cash At End Of Period
| 683.244 | 394.732 | 416.884 | 396.365 | 358.679 | 364.197 | 436.245 | 92.376 |